NCT03691246

Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 900 (estimated)
• Sponsor: China Cardiovascular Association · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is medical record review and questionnaire survey on the economic burden on Chinese patients with myocardial infarction accompanied by dyslipidemia in a real-world environment. The primary objective of the study is to investigate the economic burden of disease on patients and the factors influencing it, which may include the mode of treatment for dyslipidemia, drugs for the secondary prevention of myocardial infarction, the outcome of treatment for dyslipidemia, adverse drug reactions and major cardiovascular events. The secondary objectives of the study include: 1. patient compliance with medication; 2. health-related quality of life (HRQoL) in patients.

Detailed description

This study is a multicenter retrospective cohort survey study using a cross-sectional design. It is conducted mainly by a medical record review, questionnaire survey and medical examination to collect data.

Conditions

• Myocardial Infarction
• Dyslipidemias

Timeline

• Start date: 2018-11-15
• Primary completion: 2019-06-30
• Completion: 2019-06-30
• First posted: 2018-10-01
• Last updated: 2019-01-31

Locations

5 sites across 1 country: China